Tenet Healthcare CORP Form 4 insider transactions
NYSE
Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside new RSU grants.
NYSE
Tenet Healthcare's EVP & CFO, Sun Park, reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside a new RSU grant.
NYSE
Tenet Healthcare's EVP, Chief Information Officer, Paola M. Arbour, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Tenet Healthcare's EVP and Chief Operating Officer, Lisa Y. Foo, reported the vesting of restricted stock units and subsequent tax-related share dispositions.
NYSE
Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, reported the sale of all his directly held common stock following RSU vesting.
NYSE
Thomas W. Arnst, EVP, Chief Admin. Officer & GC of Tenet Healthcare Corp, reported significant stock transactions including RSU vesting, tax-related dispositions, and a substantial sale of common stock.
NYSE
Tenet Healthcare's EVP & Chief Financial Officer, Sun Park, converted 3,800 restricted stock units into common stock on February 24, 2026.
NYSE
Tenet Healthcare CEO Saumya Sutaria converted 18,242 restricted stock units into common stock as part of a scheduled vesting event.
NYSE
Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp., acquired 1,267 shares of common stock through the vesting of restricted stock units.
NYSE
Tenet Healthcare's EVP and Chief Operating Officer, Lisa Y. Foo, acquired 3,800 shares of common stock through the vesting of restricted stock units.
NYSE
Tenet Healthcare's EVP, Chief Administrative Officer & General Counsel, Thomas W. Arnst, acquired 3,800 shares of common stock through the vesting of restricted stock units.
NYSE
Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, converted 443 restricted stock units into common stock following the vesting of the first increment.
NYSE
Tenet Healthcare Corp. Director Nadja West reported a planned donation of 1,515 common shares to a charitable donor advised fund.
NYSE
Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share disposition on December 31, 2025.
NYSE
Tenet Healthcare Corp. Director Nadja West sold 2,178 shares of common stock at a weighted average price of $197.47.
NYSE
Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, sold all 13,322 beneficially owned shares of common stock on November 6, 2025, under a pre-arranged trading plan.
NYSE
Tenet Healthcare Director Tammy Romo sold 645 shares of common stock at $205.2 per share on November 5, 2025.
NYSE
A director at Tenet Healthcare Corp. sold over 26,000 shares of common stock for approximately $5.4 million under a pre-arranged trading plan.
NYSE
Tenet Healthcare Corp. Director Richard W. Fisher sold 2,500 shares of common stock for approximately $521,075 on October 29, 2025.
NYSE
Tenet Healthcare Corp Director J. Robert Kerrey reported a charitable contribution of 971 common shares.
NYSE
Tenet Healthcare CEO Saumya Sutaria sold 78,762 shares of common stock for approximately $15 million in two pre-arranged transactions on September 10, 2025.
NYSE
Tenet Healthcare CEO Saumya Sutaria converted restricted stock units into common stock and subsequently sold shares to cover tax obligations.
NYSE
Tenet Healthcare Director Christopher S. Lynch reported the sale of 8 shares of common stock for $183.44 per share, executed under a Rule 10b5-1 plan.
NYSE
Lisa Y. Foo, Executive Vice President and Chief Operating Officer of Tenet Healthcare Corp, sold 8,000 shares of common stock for a weighted average price of $179.53 per share under a Rule 10b5-1 trading plan.
NYSE
A Tenet Healthcare Corp. director sold 3,952 shares of common stock for $176.39 per share, reducing their beneficial ownership to 12,358 shares.
NYSE
Tenet Healthcare Corp's EVP & CFO, Sun Park, acquired 20,707 common shares through RSU vesting, with 8,813 shares withheld for tax obligations.
NYSE
Tenet Healthcare's CEO, Saumya Sutaria, was granted 106,682 shares of common stock after the company's Human Resources Committee certified the achievement of performance targets.
NYSE
Richard W. Fisher, a Director at Tenet Healthcare Corp, reported the sale of 836 shares of common stock for approximately $144,600.
NYSE
Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp., reported the sale of 7,738 shares of common stock for approximately $1.34 million.
NYSE
A director at Tenet Healthcare Corp. has sold 4,613 shares of common stock for $170 per share, reducing their direct beneficial ownership to 35,271 shares, as part of a pre-arranged 10b5-1 trading plan.